1. Home
  2. ARL vs LRMR Comparison

ARL vs LRMR Comparison

Compare ARL & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Realty Investors Inc.

ARL

American Realty Investors Inc.

HOLD

Current Price

$17.10

Market Cap

279.4M

Sector

Real Estate

ML Signal

HOLD

Logo Larimar Therapeutics Inc.

LRMR

Larimar Therapeutics Inc.

HOLD

Current Price

$5.21

Market Cap

280.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARL
LRMR
Founded
1999
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Building operators
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
279.4M
280.0M
IPO Year
1999
2014

Fundamental Metrics

Financial Performance
Metric
ARL
LRMR
Price
$17.10
$5.21
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$16.29
AVG Volume (30 Days)
2.1K
6.3M
Earning Date
01-01-0001
04-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.37
N/A
Revenue
$47,318,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$46.73
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.43
$1.61
52 Week High
$20.00
$6.42

Technical Indicators

Market Signals
Indicator
ARL
LRMR
Relative Strength Index (RSI) 54.70 63.82
Support Level $14.95 $3.18
Resistance Level $17.95 $5.37
Average True Range (ATR) 0.36 0.52
MACD -0.04 0.16
Stochastic Oscillator 50.50 66.13

Price Performance

Historical Comparison
ARL
LRMR

About ARL American Realty Investors Inc.

American Realty Investors Inc is a fully integrated externally managed real estate company. The company operates high-quality multifamily and commercial properties throughout the Southern United States and also invests in mortgage notes receivable and in land that is either held for appreciation or development. It operates in two reportable segments; the acquisition, development, ownership and management of multifamily properties (Residential); and the acquisition, development, ownership, and management of commercial properties (Commercial), which predominantly comprise office properties. Maximum revenue is generated from its Residential segment, which includes the rental of apartments and other tenants.

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

Share on Social Networks: